Pulse Biosciences Inc (NASDAQ: PLSE) open the trading on Thursday, with great promise as it jumped 5.03% to $17.74, before settling in for the price of $16.89 at the close. Taking a more long-term approach, PLSE posted a 52-week range of $6.59-$25.00.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that the giant of the Healthcare sector posted annual sales growth of -30.13% over the last 5 years. Meanwhile, its Annual Earning per share during the time was 16.53%. This publicly-traded company’s shares outstanding now amounts to $65.93 million, simultaneously with a float of $12.56 million. The organization now has a market capitalization sitting at $1.19 billion. At the time of writing, stock’s 50-day Moving Average stood at $17.69, while the 200-day Moving Average is $17.67.
Pulse Biosciences Inc (PLSE) Ownership Facts and Figures
Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Medical Instruments & Supplies industry. Pulse Biosciences Inc’s current insider ownership accounts for 81.32%, in contrast to 8.93% institutional ownership. According to the most recent insider trade that took place on Dec 11 ’24, this organization’s Former President and CEO sold 50,000 shares at the rate of 17.42, making the entire transaction reach 871,000 in total value, affecting insider ownership by 63,172. Preceding that transaction, on Dec 13 ’24, Company’s Director bought 55,256 for 17.18, making the whole transaction’s value amount to 949,298. This particular insider is now the holder of 42,328,717 in total.
Pulse Biosciences Inc (PLSE) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.
Pulse Biosciences Inc (NASDAQ: PLSE) Trading Performance Indicators
Let’s observe the current performance indicators for Pulse Biosciences Inc (PLSE). It’s Quick Ratio in the last reported quarter now stands at 11.88. The Stock has managed to achieve an average true range (ATR) of 1.23.
In the same vein, PLSE’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.90.
Technical Analysis of Pulse Biosciences Inc (PLSE)
[Pulse Biosciences Inc, PLSE] recent stats showed that its last 5-days Average volume was poorer than the volume it posted in the year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 92.72% While, its Average True Range was 1.20.
Raw Stochastic average of Pulse Biosciences Inc (PLSE) in the period of the previous 100 days is set at 35.38%, which indicates a major fall in contrast to 90.24% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 81.49% that was higher than 73.09% volatility it exhibited in the past 100-days period.
